Search clinical trials for: Planks
Total 2 results
-
Riphah International UniversityCompletedSports Physical TherapyPakistan
-
AstraZenecaCompleted
Sponsors and Collaborators
- Veeda Oncology
- Centro di Procreazione Assistita Demetra
- Mononuclear Therapeutics Ltd.
- Neuregenix
- North Karelia Hospital District
- Chengdu Nuoen Biotechnologies, Inc.
- AIDS Council of New South Wales
- ImproveCareNow (ICN)
- Grand Challenges Canada
- Equipe MiMes
- Prestige Biopharma Limited
- Bjørgene Omsorgssenter, Haugesund
- Maria Lendorf
- Bruce County Paramedic Service
- Yantai Yuhuangding Hospital，Medical College, Qingdao University
- BayCare Health System
- Women and children's hospital of Jiaxing university
- Nestor Soler Porcar, MD, PhD
- InflaRx GmbH
- Reina Sofia University Hospital
- View Full List
Medical Conditions
- Closure; Foramen Ovale
- Pulmonary Adenocarcinoma
- Skull Base Neoplasms
- Endocarditis Infective
- Tay-Sachs Disease Ganglioside
- Epidemic Hemorrhagic Fever
- Chlamydophila Infections
- Fracture Dislocation of Cervical Spine
- Painless Hysteroscopy
- Psoriasis, Arthritic
- Gullian Barre Syndrome
- Multisystem Proteinopathy
- Ewing's Family Tumors
- Fetus or Neonate Affected by External Version Before Labor
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Spine Surgeries
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Childhood Langerhans Cell Histiocytosis
- Predictors of Atrial Fibrillation Recurrences
- View Full List
Drug Interventions
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- High dose pantoprazole infusion
- Estradiol+Drospirenone
- Qingkailing injection 40 ml
- Redifferentiation with retinoid acid
- Semapimod
- Adriamycin
- Azelastine hydrochloride (BAYR9258)
- Adapalene Gel 0.3%
- Vehicle
- Cereport
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- Chemotherapeutic Agent
- Palliative care group first-line scheme
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- Glimepiride
- Neihulizumab
- Esomeprazole 40mg before
- EFV +TVA
- View Full List
CROs by country
- Contract Research Organizations in Bahamas
- Contract Research Organizations in Belarus
- Contract Research Organizations in Denmark
- Contract Research Organizations in Estonia
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Japan
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Oman
- Contract Research Organizations in Romania
- Contract Research Organizations in Saudi Arabia
- Contract Research Organizations in Singapore
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Venezuela
- CRO list by country